Skip to main navigation Skip to search Skip to main content

Libra Therapeutics Promotes Martin Gill, Ph.D., to Chief Scientific Officer

Press/Media

PeriodOct 15 2025 → Oct 16 2025

Media coverage

7

Media coverage